Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Qrons Inc (OP:QRON)

0.0111 UNCHANGED

Last Price Updated: 10:06 AM EST, Dec 10, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	0.0111
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	0.0111
Today's Range	0.0111 - 0.0111
52wk Range	0.0111 - 0.1620
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Qrons / First Person Provides Shareholder Update and Strategic Overview

July 10, 2025

Via ACCESS Newswire

First Person and Qrons Complete Merger, Creating a Publicly Traded Leader in Cognitive Wellness & Functional Beverages

February 04, 2025

Via ACCESS Newswire

Performance

YTD	N/A	N/A
1 Month	N/A	N/A
3 Month	N/A	N/A
6 Month	N/A	N/A
1 Year	-93.1%	-93.1%

More News

Qrons Announces the Addition of Professor Shiri Navon-Venezia to its Scientific Advisory Board to Beef up its Team, as Part of its New Sepsis Research Program

November 20, 2023

Via ACCESSWIRE

Qrons Announces Launch of its New Website in Furtherance of its Neuronal and Infectious Disease Treatments Development, Including Sepsis

August 23, 2023

Via ACCESSWIRE

Qrons Announces the Filing of a Provisional Patent Application in Furtherance of its Neuronal and Infectious Disease Treatments Development, Including Sepsis

August 14, 2023

Via ACCESSWIRE

Qrons Announces the Signing of a License Agreement Term Sheet as Part of New Research Program to Experiment and Commercialize the Therapeutic Effect of Certain Tellurium Based Compounds on Antibiotic Resistance Bacterial Infections, Sepsis and Traumatic

July 20, 2023

Via ACCESSWIRE

Qrons files U.S. National Phase of its Patent Application in Furtherance of its QS200 Product Candidate for Therapeutic Polypseudorotaxane Hydrogels

March 22, 2023

Via ACCESSWIRE

Qrons Announces Engagement of Israeli Intellectual Property Law Firm IPK to Develop Roadmap for Its New Product Line

January 17, 2023

Via ACCESSWIRE

Qrons Announces a New Pre-Clinical Research Program to Test the Efficacy of Tellurium Based Compounds, in Combination with its QS200(TM) Product Candidate or Independently, in Treating Diffused Axonal Injuries and Antibiotic Resistant Bacteria and Sepsis

December 14, 2022

Via ACCESSWIRE

Qrons Announces Filing Of Provisional Patent Application In Furtherance Of Its QS200 Product Candidate

April 12, 2022

From Qrons Inc.

Via AccessWire

Qrons Announces Effectiveness of Its Post-Effective Amendment to Its Registration Statement

March 28, 2022

From Qrons Inc.

Via AccessWire

Qrons Announces U.S. Patent Office Grants Dartmouth College 3D Printing Patent Forming Basis of License Agreement with Qrons

April 22, 2021

From Qrons Inc.

Via AccessWire

Frequently Asked Questions

Is Qrons Inc publicly traded?

Yes, Qrons Inc is publicly traded.

What exchange does Qrons Inc trade on?

Qrons Inc trades on the OTC Traded

What is the ticker symbol for Qrons Inc?

The ticker symbol for Qrons Inc is QRON on the OTC Traded

What is the current price of Qrons Inc?

The current price of Qrons Inc is 0.0111

When was Qrons Inc last traded?

The last trade of Qrons Inc was at 12/10/25 10:06 AM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.